Latest Breaking News On - Cyrano therapeutics inc - Page 1 : comparemela.com

Phase 2 FLAVOR clinical trial currently enrolling 150 patients to assess the safety and effectiveness of CYR-064 in treating patients with chronic smell loss following recovery from a viral infection

United statesDelray beachDave schemeliaRick geoffrionEric reissPrnewswire cyrano therapeutics incFlorida opportunity fundCyrano therapeutics incDeepwork capitalLumira venturesCyrano therapeuticsVenture partnerWork capital